Xalkori (crizotinib) has been cleared for inflammatory myofibroblastic tumours (IMT), which appear in organs like the lung, stomach, bladder or ... non-small cell lung cancer (NSCLC) in patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback